138 related articles for article (PubMed ID: 34190168)
1. Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism.
Liu J; Wu Z; Zhang J; Xie Y; Sun P; Wu H; Chang X; Zhang L; Liu F
Medicine (Baltimore); 2021 Jul; 100(26):e26441. PubMed ID: 34190168
[TBL] [Abstract][Full Text] [Related]
2. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
[TBL] [Abstract][Full Text] [Related]
3. [Splenic embolization and hepatic chemoembolization: combined transcatheter treatment of hepatocellular carcinoma in cirrhosis with hypersplenism].
Roversi R; Ricci S; Gambari PI; Castaldini L; Rossi G; Milandri G; Formica G; Dalmonte PR
Radiol Med; 1993 Apr; 85(4):444-9. PubMed ID: 8390705
[TBL] [Abstract][Full Text] [Related]
4. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients.
Han MJ; Zhao HG; Ren K; Zhao DC; Xu K; Zhang XT
Cardiovasc Intervent Radiol; 1997; 20(2):125-7. PubMed ID: 9030503
[TBL] [Abstract][Full Text] [Related]
5. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
Kim NH; Kim HJ; Cho YK; Hong HP; Kim BI
J Korean Med Sci; 2019 Aug; 34(30):e208. PubMed ID: 31373186
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous CSM-TACE with CalliSpheres
Zhou J; Feng Z; Liu S; Li X; Liu Y; Gao F; Shen J; Zhang YW; Zhao GS; Zhang M
Front Oncol; 2022; 12():998500. PubMed ID: 36530976
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.
Huang JH; Gao F; Gu YK; Li WQ; Lu LW
World J Gastroenterol; 2007 Dec; 13(48):6593-7. PubMed ID: 18161933
[TBL] [Abstract][Full Text] [Related]
9. A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
Mei J; Li SH; Wang QX; Zhong XP; Lu LH; Kan A; Wei W; Guo RP
Cancer Med; 2020 Jan; 9(1):62-76. PubMed ID: 31701652
[TBL] [Abstract][Full Text] [Related]
10. Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H; Hiraoka A; Ishimaru Y; Murakami T; Kitahata S; Ueki H; Aibiki T; Okudaira T; Miyamoto Y; Yamago H; Iwasaki R; Tomida H; Mori K; Kishida M; Tsubouchi E; Miyata H; Ninomiya T; Kawasaki H; Hirooka M; Matsuura B; Abe M; Hiasa Y; Michitaka K; Kudo M
Oncology; 2017; 93 Suppl 1():120-126. PubMed ID: 29258105
[TBL] [Abstract][Full Text] [Related]
11. Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization.
Wu ZJ; Xie YF; Chang X; Zhang L; Wu HY; Liu JB; Zhang JX; Sun P
Med Sci Monit; 2021 May; 27():e929884. PubMed ID: 33967266
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib plus partial splenic embolism for treatment of hepatocellular carcinoma Barcelona stage C combined with hypersplenism: a case series.
Zeng J; Wang C; Wang Y; Luo Z; Zhang Y; Luo X
J Int Med Res; 2021 Jun; 49(6):3000605211023351. PubMed ID: 34139869
[TBL] [Abstract][Full Text] [Related]
13. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
16. Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2.
Arizumi T; Minami T; Chishina H; Kono M; Takita M; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Kamata K; Minaga K; Komeda Y; Takenaka M; Sakurai T; Watanabe T; Nishida N; Kudo M
Dig Dis; 2017; 35(6):589-597. PubMed ID: 29040992
[TBL] [Abstract][Full Text] [Related]
17. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
Chiang CL; Chan MKH; Yeung CSY; Ho CHM; Lee FAS; Lee VWY; Wong FCS; Blanck O
Strahlenther Onkol; 2019 Mar; 195(3):254-264. PubMed ID: 30413833
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
